YTS-15748-27485
2 vaccinations
5 coded responses
19 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 238 / VA
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Moderna
-
2021-01-17
Registered in v-safe
- 2021-01-17
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Fatigue or tirednessFree text: Blood glucose levels have been elevated since time of injection and have required excess insulin every hour via basal rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Fever, headache, nausea, muscle pain, fatigue · Healthcare visit (other): Awaiting results on COVID 19 testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-04
Survey response — day 21, dose 1MedDRA: Fatigue, Headache, Myalgia, Pyrexia, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 5 days of low grade fever, extreme fatigue, muscle pain, headache. Negative COVID rapid and PCR.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: I am a type 1 diabetic and blood sugars have been elevated to between 200-300 and have required 10% extra basal rate per hourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint painsAdult check-in
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-14
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-06-09
-
2021-06-09
Callback requested for06:00PM ET
- 2021-08-14
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: Anxiety, Asthenia, COVID-19, Depression — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Infected with Omicron. Had debilitating anxiety and depression which lasted 3-4 weeks.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | |
| 2 | 2021-02-12 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-28 | Unsuccessful | |
| 2021-02-04 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Blood glucose levels have been elevated since time of injection and have required excess insulin every hour via basal rate
Release 3 — day 14, dose 1
Symptoms: Fever, headache, nausea, muscle pain, fatigue
Healthcare visit (other): Awaiting results on COVID 19 test
Release 3 — day 21, dose 1
Symptoms: 5 days of low grade fever, extreme fatigue, muscle pain, headache. Negative COVID rapid and PCR.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): I am a type 1 diabetic and blood sugars have been elevated to between 200-300 and have required 10% extra basal rate per hour
Release 11 — 12 months, dose 2
Symptoms: Infected with Omicron. Had debilitating anxiety and depression which lasted 3-4 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release